Axim Biotechnologies Inc (AXIM)

[TexasMarvL]

Fintel has a public copy of the 10-Q from 2021-November-22.

Starting on page 5 the number of shares outstanding are listed by quarter starting in 2019, but I'm only going to list the last 4 quarter ending amounts.

10.5 million shares added in first 9 months of 2021. This does not account for the 7 million shares used to acquire Dry Eye Disease division that was finalized in October 2021.

September 30, 2021
135,885,104 shares

June 30, 2021
133,024,435 shares

March 31, 2021
127,528,507

December 31, 2020
125,327,579


FIRST 9 months of 2021
Loss from continuing operations:
($6,327,494 )
NET LOSS ($7,983,134 )
Revenue $ 55,651

I'm guessing the revenue was generated from the Recombinant protein created in-house by Alim Seit-Nebi, Chief Technology Officer.



Link to Fintel.
https://fintel.io/doc/sec-axim-biotechnologies-inc-1514946-10q-2021-november-22-18953-6496